Company Quick10K Filing
Cerebain Biotech
10-Q 2019-03-31 Filed 2019-05-20
10-Q 2018-12-31 Filed 2019-02-19
10-Q 2018-09-30 Filed 2018-11-14
10-K 2018-06-30 Filed 2018-09-26
10-Q 2018-03-31 Filed 2018-05-15
10-Q 2017-12-31 Filed 2018-02-06
10-Q 2017-09-30 Filed 2017-11-09
10-K 2017-06-30 Filed 2017-09-15
10-Q 2017-03-31 Filed 2017-05-11
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-14
10-K 2016-06-30 Filed 2016-09-27
10-Q 2016-03-31 Filed 2016-05-16
10-Q 2015-09-30 Filed 2015-11-16
10-K 2015-06-30 Filed 2015-09-22
10-Q 2015-03-31 Filed 2015-05-13
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-12
10-K 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-14
10-Q 2013-12-31 Filed 2014-02-10
10-Q 2013-09-30 Filed 2013-11-12
10-K 2013-06-30 Filed 2013-09-30
10-Q 2013-03-31 Filed 2013-05-03
10-Q 2012-12-31 Filed 2013-02-12
10-Q 2012-09-30 Filed 2012-11-14
10-K 2012-06-30 Filed 2012-09-28
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-12-31 Filed 2012-02-17
10-K 2011-11-30 Filed 2012-01-12
10-Q 2011-08-31 Filed 2011-10-12
10-Q 2011-05-31 Filed 2011-07-14
10-Q 2011-02-28 Filed 2011-04-12
10-K 2010-11-30 Filed 2011-02-01
10-Q 2010-08-31 Filed 2010-10-05
10-Q 2010-05-31 Filed 2010-07-07
10-Q 2010-02-28 Filed 2010-04-09
10-K 2009-11-30 Filed 2010-03-03
8-K 2019-07-01
8-K 2019-03-01
8-K 2018-12-10
8-K 2018-03-02

Cerebain Biotech Financials

CBBT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Mercantil Bank Holding (MBHC) 0 -1.3 0% 8,435,802 7,708,127 0 0 21,974 81,045 -103,579
Bill.com (BILL)
ProGreen (PGUS) 0 0% -0.1 -176% 1,863 6,266 61 0 -3,277 -210 17
9F (JFU)
OriginClear (OCLN) 0 11% -0.4 -648% 1,287 20,610 2,696 290 -8,338 -7,771 3,125
Blue Hat Interactive (BHAT)
Daniels Corporate Advisory (DCAC) 0 22% -0.4 50% 547 2,757 2,368 525 271 343 -129
Yinghong Guangda Technology (UBLI) 0 24% 0.0 0 21 1,377 326 -1,329 -1,280 -0
Ironclad Encryption (IRNC) 0 0.0 -1,440% 585 5,116 0 0 -8,421 -7,101 -150
HyperSolar (HYSR) 0 1.4 131% 174 6,528 0 0 228 1,247 1,711
Alkame Holdings (ALKM) 0 11% -0.0 -2,776% 97 4,532 124 13 -2,695 -2,645 0
Vilacto Bio (VIBI) 0 17% -0.0 -3,636% 538 3,960 5 1 -19,550 -19,519 17
Futu (FHL)
Afya (AFYA)
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 8 1,981 0 0 -3,708 -3,708 205
Rennova Health (RNVA) 0 8% -1.3 -236% 16,574 76,464 13,138 1,065 -39,132 -22,172 28,583
Cerebain Biotech (CBBT) 0 -2.4 -7,969% 22 6,686 0 0 -1,718 -1,399 3,294
Kibush Capital (DLCR) 0 33% -0.2 -213% 178 3,452 140 46 -380 -374 88
Coates (COTE) 0 0% 0.0 -247% 2,206 8,851 10 0 -5,451 -4,482 -18
FinServ Acquisition (FSRVU)

Balance Sheet ($'000)2011-11-302011-12-312012-03-312012-06-302012-09-302012-12-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash010421000104724162500832021111143065391819
Accounts Receivable
Inventory
PP&E
Assets0848588851,0421,0567748306295524493701721782644964145914032371396912592593222
Accounts Payable6491438110171551331742202813994954905396857698169099269579731,0301,1439219811,036
Long-Term Debt1,4022,2862,5212,6732,8072,8532,8512,8512,9512,9362,9363,3133,3133,313
Liabilities235336645959441,1247641,3571,6241,7282,1802,2892,7462,8802,9653,1803,5413,8384,0504,2834,4904,6634,8175,3205,6756,1296,3246,686
Stockholders' Equity-23-449-580-506-859-82293-582-794-1,099-1,628-1,840-2,377-2,708-2,787-2,916-3,045-3,424-3,459-3,879-4,253-4,524-4,748-5,195-5,584-6,070-6,292-6,664
Income Statement ($'000)2011-11-302011-12-312012-03-312012-06-302012-09-302012-12-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue00
Cost of Revenue
Gross Profit
R&D108088890172122244135000017870625951428280903200
SG&A15613915017757481565634662344428405398453406397488390439439415289188314216194208213
Tax-000000000000000000000000000
Net Income-553-139-150-286-68-726-855-819-970-633-491-660-969-555-518-495-855-4,190-10,693-567-563-431-3,413-655-420-537-371-390
Cash Flow ($'000)2011-11-302011-12-312012-03-312012-06-302012-09-302012-12-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-88-159-162-1-162-300-282-130-188-184-272-67-75-87-231-171-199-186-61-219-165-197-323-65-101-144
Cash Investing-20000000
Cash Financing89163160101634031851251901952814375942261891801866023015520034810075145